A 1 Mb minimal amplicon at 8p11–12 in breast cancer identifies new candidate oncogenes
María J. García(Spanish National Cancer Research Centre), Carlos Caldas(University of Cambridge), Suet‐Feung Chin(University of Cambridge), Jessica C. Pole(University of Cambridge), Andrew E. Teschendorff(Shanghai Institute of Nutrition and Health), Tatiana Subkhankulova(University of Cambridge), Claire E. Paish(University of Nottingham), Tanja Kranjac(University of Cambridge), Paul A. Edwards(University of Cambridge), Hi̇lal Özdağ(University of Cambridge), Ian O. Ellis(University of Nottingham), Maria Vias(University of Cambridge), James D. Brenton(Cambridge University Hospitals NHS Foundation Trust), Ali Naderi(University of Hawaiʻi at Mānoa)
Cited by 166
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
The clonal and mutational evolution spectrum of primary triple-negative breast cancers
|Nature|2012|2k
Rethinking ovarian cancer: recommendations for improving outcomes
|Nature reviews. Cancer|2011|1.5k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k